Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

4.3%

1 terminated/withdrawn out of 23 trials

Success Rate

92.9%

+6.4% vs industry average

Late-Stage Pipeline

35%

8 trials in Phase 3/4

Results Transparency

0 of 13 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

13(59.1%)

Phase 3

4(18.2%)

Phase 4

4(18.2%)

Phase 2

1(4.5%)

22Total

N/A(13)

Phase 3(4)

Phase 4(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials

NCT03438838Not ApplicableUnknown

Randomised Trial Between LHM Alone Vs LHM With Anterior Fundoplication In Achalasia Cardia

Role: lead

NCT02077062Terminated

Study of Mediators of Post Hepatectomy Liver Regeneration

Role: lead

NCT03722732Not ApplicableUnknown

Comparison of Blood Loss in Laparoscopic vs Open Pancreaticoduodenectomy in Patients With Periampullary Carcinoma

Role: lead

NCT02185664Not ApplicableCompleted

Use of Static Ultrasound Guidance for Internal Jugular Vein Cannulation in Adult Cardiac Surgical Patients

Role: lead

NCT01446523Not ApplicableCompleted

S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE

Role: lead

NCT01412567Not ApplicableCompleted

Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers

Role: lead

NCT01022463Phase 3Completed

Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm

Role: lead

NCT01356121Phase 4Unknown

Trial Comparing Sedation for Endoscopy With Propofol Versus Midazolam in Cirrhotics

Role: lead

NCT01267669Not ApplicableCompleted

A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding

Role: lead

NCT01000779Phase 3Completed

Comparison of Endoscopic Variceal Ligation (EVL) With Propranolol in Non Cirrhotic Portal Hypertension (NCPH)

Role: lead

NCT01200732Phase 2Completed

Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome

Role: lead

NCT01178372Phase 4Unknown

Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis

Role: lead

NCT01175538Phase 4Unknown

Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis

Role: lead

NCT01134692Phase 3Unknown

Probiotics for Portal Hypertension

Role: lead

NCT01074645Phase 4Completed

Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure

Role: lead

NCT00772057Not ApplicableCompleted

Beta-blockers for Prevention Of Growth Of Small Esophageal Varices In Cirrhosis: An Randomized Controlled Trial (RCT)

Role: lead

NCT01036932Not ApplicableUnknown

Granulocyte Colony Stimulating Factor(G-CSF) Therapy for Patients With ACLF

Role: lead

NCT00947336Phase 3Completed

Evaluation of Safety & Efficacy of Synbiotic on the Incidence and Recurrence of Spontaneous Bacterial Peritonitis (SBP) in Cirrhotics

Role: lead

NCT00905996Not ApplicableCompleted

Primary Prophylaxis of Gastric Varix Bleed

Role: lead

NCT00888784Not ApplicableCompleted

Secondary Prophylaxis Gastric Variceal Bleed

Role: lead